Results 231 to 240 of about 86,997 (265)
Some of the next articles are maybe not open access.
Viral Immunology, 2018
Vaccines are essential tools for the prevention and control of infectious diseases in animals. One of the most important steps in vaccine development is the selection of a suitable adjuvant. The focus of this review is the adjuvants used in vaccines for animals.
Yulia, Burakova +4 more
openaire +2 more sources
Vaccines are essential tools for the prevention and control of infectious diseases in animals. One of the most important steps in vaccine development is the selection of a suitable adjuvant. The focus of this review is the adjuvants used in vaccines for animals.
Yulia, Burakova +4 more
openaire +2 more sources
Seminars in Immunology, 2010
The recent FDA approval of sipuleucel-T (Provenge), a patient-specific immunotherapy for androgen-independent prostate cancer developed by Dendreon Corporation, has provided support for the concept of cellular immunotherapy as an approach to cancer treatment.
Thomas W, Dubensky, Steven G, Reed
openaire +2 more sources
The recent FDA approval of sipuleucel-T (Provenge), a patient-specific immunotherapy for androgen-independent prostate cancer developed by Dendreon Corporation, has provided support for the concept of cellular immunotherapy as an approach to cancer treatment.
Thomas W, Dubensky, Steven G, Reed
openaire +2 more sources
Vaccine adjuvants: A priority for vaccine research
Vaccine, 2010The workshop on vaccine adjuvants was held in July of 2009 at the European Commission in Brussels, with the goal of identifying key scientific priorities as they pertain to the development of effective vaccines against life-threatening diseases especially those associated with poverty, including HIV/AIDS, malaria and tuberculosis as well as neglected ...
Harandi AM +29 more
openaire +3 more sources
Self-Adjuvanting Lipopeptide Vaccines
Current Medicinal Chemistry, 2008Despite the important role of adjuvants for vaccine development, relatively few adjuvants have been successfully incorporated into vaccines intended for human administration. This is in part due to the high toxicity associated with many experimental adjuvants. This lack of choice effectively hinders the ability to produce vaccines against many diseases,
Moyle, P.M., Toth, I.
openaire +5 more sources
Nanoparticles as Adjuvants for Vaccines
1995PMMA nanoparticle adjuvants can be manufactured in a physicochemically reproducible manner. Their particle size can be controlled within narrow limits. Immunogens may be either incorporated or adsorbed to these nanoparticles. PMMA nanoparticles induced significantly higher and more prolonged antibody responses against a variety of immunogens, including
openaire +2 more sources
Archaeosomes as Adjuvants for Combination Vaccines
Journal of Liposome Research, 2004The present study evaluated the potential of archaesomes, prepared from the total polar lipids extracted from Methanobrevibacter smithii, as adjuvants for combination (multivalent) vaccines. Groups of Balb/c mice were immunized subcutaneously at day 0 and 21 with one of the following vaccines: trivalent vaccine formulated by the simultaneous co ...
Patel, Girishchandra B. +3 more
openaire +2 more sources
Recent advances on chitosan as an adjuvant for vaccine delivery
International Journal of Biological Macromolecules, 2022Isra Dmour, Nazrul Islam
exaly
The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery
Cell, 2018Yonghua Xie, Meng Zhao, Zhaoyun Zong
exaly
Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development
Trends in Biotechnology, 2019Saikat Manna +2 more
exaly